Related Experiment Video

Updated: Aug 30, 2025

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer
06:21

Author Spotlight: Genetic Profiling for Fluorouracil Response in Gastric Cancer

Published on: May 10, 2024

832

FGFR2 Exon 18 Truncation Variants Are Therapeutically Actionable in Cancer

    Cancer Discovery
    |August 26, 2022
    PubMed

    Insights

    Fibroblast growth factor receptor 2 (FGFR2) exon 18 truncation variants act as oncogenic drivers. These genetic alterations are key in cancer development, highlighting FGFR2's role in tumorigenesis.

    Area of Science:

    • Oncology
    • Molecular Biology
    • Genetics

    Background:

    • Fibroblast growth factor receptor 2 (FGFR2) is implicated in various cancers.
    • Specific mutations in FGFR2 can drive tumor growth and progression.

    Purpose of the Study:

    • To investigate the functional role of FGFR2 exon 18 truncation variants.
    • To determine if these variants act as oncogenic drivers.

    Main Methods:

    • Analysis of genetic variants in cancer patient cohorts.
    • Functional assays to assess the oncogenic potential of FGFR2 exon 18 truncations.

    Main Results:

    • Variants leading to FGFR2 exon 18 truncation were identified.
    • These specific variants demonstrated oncogenic driver activity in experimental models.

    Conclusions:

    • FGFR2 exon 18 truncation variants are confirmed oncogenic drivers.
    • Targeting these specific FGFR2 alterations may offer therapeutic strategies.

    More Related Videos

    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay10:57

    Visualizing Genetic Variants, Short Targets, and Point Mutations in the Morphological Tissue Context with an RNA In Situ Hybridization Assay

    Published on: August 14, 2018

    10.8K
    Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors09:22

    Functional Assessment of BRCA1 variants using CRISPR-Mediated Base Editors

    Published on: February 28, 2021

    5.6K

    Related Concept Videos

    Cancer-Critical Genes II: Tumor Suppressor Genes01:05

    Cancer-Critical Genes II: Tumor Suppressor Genes

    Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
    When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
    Such genes that act...
    7.9K
    RNA Splicing01:32

    RNA Splicing

    Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
    56.7K
    Alternative RNA Splicing02:18

    Alternative RNA Splicing

    Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
    There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
    21.6K